Chelmsford VA CMOP_6 Line Items_Pharm
ID: 36C77025Q0035Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/7bc91b8a81b74550a13222bfda9091f2/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.

    Point(s) of Contact
    Lacie A Nowak
    lacie.nowak@va.gov
    Files
    Title
    Posted
    36C77025Q0035_1.pdf
    The document represents a Request for Proposal (RFP) from the Department of Veterans Affairs, specifically for the procurement of pharmaceutical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP). The RFP outlines key information regarding submission and compliance requirements for potential contractors, including the need for specific product certifications, shipping guidelines, and invoicing procedures. It highlights the importance of using compliant National Drug Codes (NDCs), adhering to the Drug Supply Chain Security Act, and illustrates the contractor's responsibility in validating product availability and pricing leading up to purchase orders. Delivery logistics target a 10-day timeline for acceptance and detail requirements for packaging and labeling, including barcoding standards. The document emphasizes strict compliance with federal acquisition regulations and mandates quantifiable product performance to ensure quality and timely delivery. It also delineates various clauses related to administrative oversight, invoicing specifics, potential recalls, and terms of contract execution, underscoring the VA's commitment to acquiring safe, effective, and affordable medical supplies for veterans. Overall, this RFP underscores the VA's dedication to procuring pharmaceutical products through a transparent and regulated procurement process, aiming to enhance service delivery to veterans while ensuring compliance with established laws and standards.
    36C77025Q0035_2.docx
    The Department of Veterans Affairs (VA), Network Contracting Office 15, is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The solicitation will open on January 3, 2025, with a response deadline of January 17, 2025, at 3 PM Central Time. The pharmaceutical products sought include items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, among others, with specific quantities and packaging outlined. Interested vendors must comply with the Drug Supply Chain Security Act and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to be deemed compliant. Quotations should be emailed to the designated contract specialist, and must include required forms such as the signed SF1449 cover page and Buy American Act certificate. This solicitation reflects the VA's ongoing commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations.
    S02_Pricing Schedule_Q0035.xlsx
    The document pertains to a Request for Quotations (RFQ) issued for the Chelmsford CMOP facility, identified by RFQ number 36C77025Q0035. It details the procurement process for pharmaceuticals and medical surgical supplies, requiring vendors to submit their quotes by January 17, 2025, 3:00 PM CT. Essential documents include the signed SF1449 cover page and a completed quote spreadsheet with specific information on required product quantities, prices, and expiration dates. Vendors must affirm compliance with the Trade Agreements Act and verify possession of a valid State Wholesale Distributor License. The list of line items specifies product descriptions, manufacturer details, and unit quantities, alongside a total price section. The intent is to ensure that all products delivered have a minimum shelf life of one year at the time of delivery and emphasizes the need for clear communication regarding any alternative National Drug Codes proposed by vendors. This RFQ exemplifies the government's structured approach to sourcing necessary medical supplies while adhering to regulatory requirements and ensuring competitive vendor engagement.
    Lifecycle
    Title
    Type
    Chelmsford VA CMOP_6 Line Items_Pharm
    Currently viewing
    Combined Synopsis/Solicitation
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Presolicitation
    Similar Opportunities
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0108 770-25-1-801-0136 -National CMOP FENOFIBRATE 48mg
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate 48mg tablets for the National CMOP (Consolidated Mail Outpatient Pharmacy) facility. The solicitation, numbered 36C77025Q0108, requires vendors to provide specific quantities of the medication, with strict adherence to the Drug Supply Chain Security Act and the Buy American statute. This procurement is critical for ensuring the timely delivery of essential pharmaceuticals to veterans, with a closing date for submissions set for January 8, 2025, at 9:00 AM CST, and an estimated award date of January 13, 2025. Interested parties should submit their quotes and required documentation, including a signed SF1449 form and state wholesale distributor license, to Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0109 770-25-2-801-0180 -National CMOP SEVELAMER CARBONATE 800MG
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Sevelamer Carbonate 800mg tablets for delivery to multiple CMOP facilities. The solicitation requires vendors to provide detailed quotes in Excel format, including compliance with the Drug Supply Chain Security Act and adherence to the Buy American statute, which emphasizes the preference for U.S.-made products. This procurement is critical for ensuring the availability of essential pharmaceuticals to support the healthcare needs of veterans. Interested vendors must submit their quotes by January 13, 2025, with the anticipated award date set for January 16, 2025; for further inquiries, contact Michael W McAlhaney at Michael.McAlhaney@va.gov or call (913) 684-0134.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0051 762-25-1-040-0048 -Tucson CMOP FEXOFENADINE HCL -(VA-25-00013424)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Fexofenadine HCL 180mg tablets for delivery to the Tucson CMOP facility. This procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that vendors submit specific documentation, including a signed SF-1449 cover page, a completed price schedule in Excel format, and proof of state wholesale distributor licensure. The pharmaceuticals are critical for ensuring the health and well-being of veterans, reflecting the government's commitment to providing quality medical supplies. Interested vendors must submit their quotes by January 10, 2025, with an estimated award date of January 13, 2025; for further inquiries, contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or call (913) 684-0142.
    6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.
    6515--Pharmacy Omnicell XT 2-Cell Medication Cabinet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking offers for the procurement of a Pharmacy Omnicell XT 2-Cell Medication Cabinet for the VA Phoenix Healthcare System. This solicitation, identified by Request for Quotes (RFQ) number 36C26225Q0313, aims to enhance medication management capabilities within the facility, emphasizing features such as user access controls and inventory management. The contract will be awarded as a Firm Fixed Price agreement, with a performance period of 365 days from the award date. Interested vendors must submit their offers electronically by January 16, 2025, and direct any inquiries to Contracting Officer Victor Oliveros at victor.oliveros@va.gov by January 13, 2025.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.